- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05284292
GUARDIAN: The Social Robot Companion to Support Homecare Nurses (GUARDIAN)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to verify the acceptability of the GUARDIAN platform by the elderly, detected through the scale Unified Theory of Acceptance and Use of Technology (UTAUT). The aim of this project is to enable the older adult to live as long as possible at home, involving the informal caregiver, using the available technologies. The GUARDIAN platform consists of the Senior App, the Caregiver App and the Misty II robot. The Senior App is an easy-to-use application that will ask the elderly for health status, whether they have carried out their daily activities, if they have taken pre-establishable drugs and if they have eaten properly. The application will generate self-reports that will be transmitted to the app caregiver. The elderly can answer the questions via a tablet on the robot or by voice. The Caregiver App is the application intended for the caregiver, in which you can set up reminders for the elderly about meals or drugs, send communications and ask for reports on his health. This application will be used by both the informal caregiver and the formal caregiver (health care professional). It is the social robot that will complete the platform. Reminders will be sent via the robot and questions will be asked to the patient. The trial will consist of two phases involving, in each of the three participant countries (Italy, Nederlands and Switzerland), 4 seniors with their informal caregivers in the Alpha phase and 10 seniors with their informal caregivers in the following GUARDIAN trial. In both phases the presence of a formal caregiver is expected. In the Alpha phase 4 users and their caregivers will use a first version of the GUARDIAN platform, for three months. The results and feedback from the Alpha phase will give indications to improve and refine the platform.
The GUARDIAN trial involves the enrollment of 10 elderly people in each of the three participant countries (different from those recruited in the Alpha phase) and their respective informal caregivers. The evaluations will be carried out at baseline (T0) and then every month, for three months (T1, T2, T3).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ancona, Italy, 60127
- Irccs Inrca
-
-
-
-
-
Harderwijk, Netherlands
- Hospital St Jansdal
-
-
-
-
-
Geneve, Switzerland, CH-1211
- Hôpitaux Universitaires de Genève
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Cognitive integrity (Mini Mental State Examination >=24)
- Have an informal caregiver
- Healthy sight and hearing
Exclusion Criteria:
- Mini Mental State Examination < 24
- Lack of informal caregivers
- Sight and hearing not intact
- Lack of informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental arm
The Guardian platform consists of the robot Misty II, the Senior App and the Caregiver App will be tested by the elderly subjects together with their caregivers
|
The enrolled elderly subjects and their caregivers will use at home the GUARDIAN platform consists of the Senior App, the Caregiver App and the Misty II robot.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the acceptability of the GUARDIAN platform
Time Frame: change from baseline to 1, 2 and 3 months after intervention commencement
|
Acceptability will be assessed using a 32-item questionnaire based on the unified theory of acceptance and use of technology (UTAUT) model. It's a standardized instrument for measuring the likelihood of success for new technology introductions and helps to understand the drivers of its acceptance. The questionnaire has 32 questions distributed in 4 key constructs: 1) performance expectancy, 2) effort expectancy, 3) social influence, and 4) facilitating conditions. Each question are based on a Likert-type 5-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Increments are integers between 1 to 5. |
change from baseline to 1, 2 and 3 months after intervention commencement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Care load of the informal caregiver
Time Frame: change from baseline to 1, 2 and 3 months after intervention commencement
|
Zarit Burden Interview (Chattat R. et al. 2011)
|
change from baseline to 1, 2 and 3 months after intervention commencement
|
|
Caregiver's Stress and Anxiety
Time Frame: change from baseline to 1, 2 and 3 months after intervention commencement
|
The General Anxiety Disorder-7 (GAD-7) is used to measure the severity of anxiety. Score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater. |
change from baseline to 1, 2 and 3 months after intervention commencement
|
|
Quality of life of the elderly
Time Frame: change from baseline to 1,2 and 3 months after intervention commencement
|
The Euro QoL 5D-5L quality of life scale is a survey of perceived quality of life that consists of 5 domains: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression; each domain is evaluated with an inverse Likert scale of 5 points where 1 indicates the absence of a problem and 5 the most extreme problem.
It also consists of a subscale that evaluates the level of global health through a visual analog scale of 100 points.
A unique health state is defined by combining 1 level from each of the 5 dimensions, this combination can be converted into a single index value by facilitating the calculation of quality-adjusted life years (QALYs).
|
change from baseline to 1,2 and 3 months after intervention commencement
|
|
Elderly person's perception of their health
Time Frame: change from baseline to 1, 2 and 3 months after intervention commencement
|
SF-12 Health Survey (SF-12) is composed of 12 items that produce two measurements related to two different aspects of health: physical health and mental health
|
change from baseline to 1, 2 and 3 months after intervention commencement
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- INRCA_001_2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver
-
The Wright InstituteRecruitingCaregiver Burden | Caregiver Stress Syndrome | Caregiver Burnout | Caregiver Awareness | Caregiver Stress | Caregiver Resilience and Stress | Caregiver Exhaustion | Caregiver Distress | Caregiver Health Related QOL | Caregiver Burden for Those Who Care for Adults With Impaired Functional Status | Caregiver... and other conditionsUnited States
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesRecruitingCaregiver | Family Caregivers | Caregiver Distress | Caregiver to a Young Adult With Early PsychosisUnited States
-
Tan Tock Seng HospitalRecruitingCaregiver | Caregiver Stress | Caregiver Resilience and StressSingapore
-
Case Comprehensive Cancer CenterWithdrawnCaregiver Distress | Caregiver Anxiety | Caregiver Health Related QOL
-
Centre integre universitaire de sante et de services...Enrolling by invitationCaregivers | Health | Caregiver Wellbeing | Caregiver Mental HealthCanada
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesRecruitingCaregiver Burnout | Care Giving Burden | Caregiver Wellbeing | Care BurdenUnited States
-
The University of Hong KongRecruitingCaregiver Burnout | Caregiver WellbeingHong Kong
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesCompletedCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
-
Fatma Beyza AkdenizNot yet recruitingChildhood Cancer | Caregiver | Childhood Cancers | Caregiver Subjective Burden | Primary Caregivers of Children Newly Diagnosed With Cancer | Caregiver Anxiety | Caregiver Health Related QOL
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesCompletedCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
Clinical Trials on GUARDIAN platform
-
Medtronic DiabetesCompletedType 1 Diabetes Mellitus | Type2 Diabetes MellitusUnited States
-
University Hospital PadovaUniversity of PadovaRecruitingInfant Development | Neurodevelopmental Abnormality | Hypoglycemia NeonatalItaly
-
TurnCare Inc.UnknownIschemic StrokeUnited States
-
Kangbuk Samsung HospitalMedtronicCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
University of AlbertaCompleted
-
University of OklahomaCompletedWeight Gain | Feeding Disorder Neonatal | Very Low Birth Weight InfantUnited States
-
University of Texas at AustinNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthma in ChildrenUnited States
-
Medtronic DiabetesCompletedDiabetes MellitusFrance, Germany, Israel, Italy, Slovenia, Sweden, United Kingdom
-
Centre Hospitalier Universitaire de NiceRecruitingHyperglycemia | Shock, Septic | HypotensionFrance
-
Medtronic DiabetesCompletedDiabetes MellitusChina